These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 15997268

  • 1. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
    Armstrong D, Veldhuyzen SJ, Chung SA, Shapiro CM, Dhillon S, Escobedo S, Chakraborty BK, Mann V, Tanser L, Nevin K.
    Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
    [Abstract] [Full Text] [Related]

  • 2. [Psychometric validation of the Polish translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) Questionnaire in patients with reflux disease].
    Kulich KR, Reguła J, Stasiewicz J, Jasinski B, Carlsson J, Wiklund I.
    Pol Arch Med Wewn; 2005 Mar; 113(3):241-9. PubMed ID: 16128281
    [Abstract] [Full Text] [Related]

  • 3. Psychometric validation of the Hungarian translation of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with reflux disease.
    Kulich RK, Ujszászy L, Tóth GT, Bárány L, Carlsson J, Wiklund I.
    Orv Hetil; 2004 Mar 28; 145(13 Suppl 2):723-9, 739-44. PubMed ID: 15125325
    [Abstract] [Full Text] [Related]

  • 4. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study.
    Kulich KR, Madisch A, Pacini F, Piqué JM, Regula J, Van Rensburg CJ, Ujszászy L, Carlsson J, Halling K, Wiklund IK.
    Health Qual Life Outcomes; 2008 Jan 31; 6():12. PubMed ID: 18237386
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.
    Nakada K, Matsuhashi N, Iwakiri K, Oshio A, Joh T, Higuchi K, Haruma K.
    World J Gastroenterol; 2017 Jul 28; 23(28):5216-5228. PubMed ID: 28811716
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T, Harada K, Hatta H, Tokura T, Oshiro Y, Nishizaki T, Obata T, Mori M, Fueki T, Fujimoto S, Haruna Y, Kuwabara A, Yorimitsu D, Ihoriya C, Kadoya H, Itano S, Fujimoto Y, Komai N, Sasaki T, Kashihara N.
    Clin Exp Nephrol; 2016 Feb 28; 20(1):134-42. PubMed ID: 26026991
    [Abstract] [Full Text] [Related]

  • 7. Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease.
    Kulich KR, Malfertheiner P, Madisch A, Labenz J, Bayerdörffer E, Miehlke S, Carlsson J, Wiklund IK.
    Health Qual Life Outcomes; 2003 Oct 28; 1():62. PubMed ID: 14613560
    [Abstract] [Full Text] [Related]

  • 8. Validation of the Reflux Disease Questionnaire for a German population.
    Nocon M, Kulig M, Leodolter A, Malfertheiner P, Willich SN.
    Eur J Gastroenterol Hepatol; 2005 Feb 28; 17(2):229-33. PubMed ID: 15674102
    [Abstract] [Full Text] [Related]

  • 9. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
    Takeuchi T, Takahashi Y, Kawaguchi S, Ota K, Harada S, Kojima Y, Sakamoto H, Kuramoto T, Kojima K, Sanomura M, Hoshimoto M, Higashino T, Itabashi T, Takada K, Sakaguchi M, Tominaga K, Kusano M, Higuchi K.
    J Gastroenterol Hepatol; 2018 Mar 28; 33(3):623-630. PubMed ID: 28865098
    [Abstract] [Full Text] [Related]

  • 10. Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    Isshi K, Matsuhashi N, Joh T, Higuchi K, Iwakiri K, Kamiya T, Manabe N, Ogawa M, Arihiro S, Haruma K, Nakada K.
    J Gastroenterol; 2019 Jun 28; 54(6):492-500. PubMed ID: 30673836
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.
    Kawara F, Fujita T, Morita Y, Uda A, Masuda A, Saito M, Ooi M, Ishida T, Kondo Y, Yoshida S, Okuno T, Yano Y, Yoshida M, Kutsumi H, Hayakumo T, Yamashita K, Hirano T, Hirai M, Azuma T.
    World J Gastroenterol; 2017 Mar 21; 23(11):2060-2067. PubMed ID: 28373773
    [Abstract] [Full Text] [Related]

  • 12. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life.
    Takeshima F, Hashiguchi K, Onitsuka Y, Tanigawa K, Minami H, Matsushima K, Akazawa Y, Shiozawa K, Yamaguchi N, Taura N, Ohnita K, Ichikawa T, Isomoto H, Nakao K.
    Med Sci Monit; 2015 Dec 31; 21():4111-21. PubMed ID: 26719012
    [Abstract] [Full Text] [Related]

  • 13. Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux disease.
    Engels LG, Klinkenberg-Knol EC, Carlsson J, Halling K.
    Health Qual Life Outcomes; 2010 Aug 17; 8():85. PubMed ID: 20716328
    [Abstract] [Full Text] [Related]

  • 14. [Psychometric validation of translation to Spanish of the gastrointestinal symptoms rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) in patients with gastroesophageal reflux disease].
    Kulich KR, Piqué JM, Vegazo O, Jiménez J, Zapardiel J, Carlsson J, Wiklund I.
    Rev Clin Esp; 2005 Dec 17; 205(12):588-94. PubMed ID: 16527180
    [Abstract] [Full Text] [Related]

  • 15. Clinical Validity and Reliability of the Malay Language Translations of Gastroesophageal Reflux Disease Questionnaire and Quality of Life in Reflux and Dyspepsia Questionnaire in a Primary Care Setting.
    Vadivelu S, Ma ZF, Ong EW, Hassan N, Nik Hassan NFH, Syed Abdul Aziz SH, Kueh YC, Lee YY.
    Dig Dis; 2019 Dec 17; 37(2):100-107. PubMed ID: 30384376
    [Abstract] [Full Text] [Related]

  • 16. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials.
    Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun AN, Thomson AB, Mann V, Escobedo S, Chakraborty B, Nevin K.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):521-9. PubMed ID: 16441473
    [Abstract] [Full Text] [Related]

  • 17. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
    Paré P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R.
    Can J Gastroenterol; 2003 May 15; 17(5):307-12. PubMed ID: 12772004
    [Abstract] [Full Text] [Related]

  • 18. Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors.
    Rydén A, Denison H, Karlsson M, Vakil N.
    Scand J Gastroenterol; 2013 Sep 15; 48(9):1018-26. PubMed ID: 23919738
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.
    Matsuhashi N, Kudo M, Yoshida N, Murakami K, Kato M, Sanuki T, Oshio A, Joh T, Higuchi K, Haruma K, Nakada K.
    J Gastroenterol; 2015 Dec 15; 50(12):1173-83. PubMed ID: 25851931
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.
    Mönnikes H, Bardhan KD, Stanghellini V, Berghöfer P, Bethke TD, Armstrong D.
    Digestion; 2007 Dec 15; 75 Suppl 1():41-7. PubMed ID: 17489031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.